INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (288531,24412,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288532,24412,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288542,24428,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288543,24428,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288544,24428,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288554,27680,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288555,27680,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288556,27680,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288566,27830,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288567,27830,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288568,27830,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288578,31059,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288579,31059,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288580,31059,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288590,31060,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288591,31060,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'789c95566d6e1b3710bd0aff144880ad6a07cd01d4a828043876503b07a0c89196009764f92179ffe50eed097392be2177b5926d04edbf95c8f97a33ef0d370f8feb3f7e17ebfb8d586f3e6fefb78f4f7fae9fb60ff762e3933c90f07be19fc7ec9571c224a129531c8c232d76a328f8816f112905ef12adc4534f62efadf527e30e42371fc6ed7d1c6436befad8c904f3020b9171fd28a3f125c1c9c10ce492904ec3441b552d12bec5811c456945e1185ba78baace7c148fd90cc536dfc8f54eeef0e7d6e5288fe4d82d8297c4a7ef7434410c947bafdf731e1cdc3b3b0aa914852c7796a663f62435ca34098eaa6f54500dcc65f0741ddc72f095582b5560454279e4e12d1fb169fd0fdfe78cf6808913a194c865232d6cdd721cca10388a87316215d503fea3515411da47faabc04c0cde99ec23e30de74898dc21f7fc5de34bd550ac369401624f32e6968d8c241c292420e378ae31c93dbdacff720efe0716dbfd7948aeb2d991f20389ecbd08fe44715f6c37f99caa57d2e19690bb5842469352f62190ee6a21532aea6554f630c71b4a527c5450e3c9582b92c7a5937434c1fcc68c70df85f3eee773ad9cb504104037795b6aa0d4fb6235679732a024bd125ffa110eac3f2027b2a4b8ef23009e6dd28551e1f1a7679e39519c466f8b2ba9a033ca44550638756809c8047022056e522dacde3967c15d78ab88efdffef65cfe9d78777b03d726a73aee007c57890bfa850c7659a07a321895dbeee6e6860dcee5f7a3e6be33858de5296bcc3ebb9893e844f41983c484bd6edfcee76cb9c1f82b955a818fbe1c7a31986738ee6664934096c3d75f863bb445ebea653a0232353fce81a9736efa0c01bcd7791d53a6019f2d40c38a5a3570c578e6ff422bb89b292b270e03a2b7a8dbe0c058306b59e6e8a2bfce8393b5628cf02d7bfd500b349359bd3ec891ef1ea2d4a576c23815a92a232b2dff8018e6c4517fe0b04383b3b1add0995e22c80c1238d14b661a39280ccb9b493ddc9f7a83923110c90cc6cac8fe1cebb39d495b45fc8554742cf27522667e654c5963232334c9911a3ba14bd38c76883155f44a8d16b426f9621271dc65d9ccfd5aae6a93d8897185511a06d2a6b5681a3e3ab21efa4572fa31500d793479e49eb7aa34cb1a346f251e9e47ac968b10b3ea11129ac76ba893d2d26bdfb39882755099cc867494b65426eca691693bd1f05609ac0eca480cc0a765277cf12983dcb90ce2eb94f06f96501440bedc60dbf306131b5e619fdb8e7afffddb3f4fcbc486c5db6ef2d231b550c4af930c5c89f8348052eb56e92b1178a501b5ea589c90f86c945876c7057766f42526645cb55226318ea0f8d55a410db72fa4ea32c969091c0ca010720fc7e0aac52f449ce43e58a9909c447fc09f3c4c23b07510ab608979cb0f0230bc6df83546bc867ef39150f5265c887992966b5904ef6345a963af1f7f4236cfa839b116fcc88ce169bcbb7dab173df268446ded58e6b126c69a7d861c761fe6aeeae843621d00e4d84158142ed777928ee580dde1793fa72b77296039c1e1d1a4a63bbc46786e4c5d962c4cac1db5d7956fd64fad0a78a655b1b87e1974280cafb3236be95c2d1b2f1a1ef8c59857ff02c2e4d2ad','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288592,31060,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288602,33710,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'789c95566d6e1b3710bd0aff144880ad6a07cd01d4a828043876503b07a0c89196009764f92179ffe50eed097392be2177b5926d04edbf95c8f97a33ef0d370f8feb3f7e17ebfb8d586f3e6fefb78f4f7fae9fb60ff762e3933c90f07be19fc7ec9571c224a129531c8c232d76a328f8816f112905ef12adc4534f62efadf527e30e42371fc6ed7d1c6436befad8c904f3020b9171fd28a3f125c1c9c10ce492904ec3441b552d12bec5811c456945e1185ba78baace7c148fd90cc536dfc8f54eeef0e7d6e5288fe4d82d8297c4a7ef7434410c947bafdf731e1cdc3b3b0aa914852c7796a663f62435ca34098eaa6f54500dcc65f0741ddc72f095582b5560454279e4e12d1fb169fd0fdfe78cf6808913a194c865232d6cdd721cca10388a87316215d503fea3515411da47faabc04c0cde99ec23e30de74898dc21f7fc5de34bd550ac369401624f32e6968d8c241c292420e378ae31c93dbdacff720efe0716dbfd7948aeb2d991f20389ecbd08fe44715f6c37f99caa57d2e19690bb5842469352f62190ee6a21532aea6554f630c71b4a527c5450e3c9582b92c7a5937434c1fcc68c70df85f3eee773ad9cb504104037795b6aa0d4fb6235679732a024bd125ffa110eac3f2027b2a4b8ef23009e6dd28551e1f1a7679e39519c466f8b2ba9a033ca44550638756809c8047022056e522dacde3967c15d78ab88efdffef65cfe9d78777b03d726a73aee007c57890bfa850c7659a07a321895dbeee6e6860dcee5f7a3e6be33858de5296bcc3ebb9893e844f41983c484bd6edfcee76cb9c1f82b955a818fbe1c7a31986738ee6664934096c3d75f863bb445ebea653a0232353fce81a9736efa0c01bcd7791d53a6019f2d40c38a5a3570c578e6ff422bb89b292b270e03a2b7a8dbe0c058306b59e6e8a2bfce8393b5628cf02d7bfd500b349359bd3ec891ef1ea2d4a576c23815a92a232b2dff8018e6c4517fe0b04383b3b1add0995e22c80c1238d14b661a39280ccb9b493ddc9f7a83923110c90cc6cac8fe1cebb39d495b45fc8554742cf27522667e654c5963232334c9911a3ba14bd38c76883155f44a8d16b426f9621271dc65d9ccfd5aae6a93d8897185511a06d2a6b5681a3e3ab21efa4572fa31500d793479e49eb7aa34cb1a346f251e9e47ac968b10b3ea11129ac76ba893d2d26bdfb39882755099cc867494b65426eca691693bd1f05609ac0eca480cc0a765277cf12983dcb90ce2eb94f06f96501440bedc60dbf306131b5e619fdb8e7afffddb3f4fcbc486c5db6ef2d231b550c4af930c5c89f8348052eb56e92b1178a501b5ea589c90f86c945876c7057766f42526645cb55226318ea0f8d55a410db72fa4ea32c969091c0ca010720fc7e0aac52f449ce43e58a9909c447fc09f3c4c23b07510ab608979cb0f0230bc6df83546bc867ef39150f5265c887992966b5904ef6345a963af1f7f4236cfa839b116fcc88ce169bcbb7dab173df268446ded58e6b126c69a7d861c761fe6aeeae843621d00e4d84158142ed777928ee580dde1793fa72b77296039c1e1d1a4a63bbc46786e4c5d962c4cac1db5d7956fd64fad0a78a655b1b87e1974280cafb3236be95c2d1b2f1a1ef8c59857ff02c2e4d2ad','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288603,33710,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288604,33710,'6d7d1280-f286-4f39-89f3-2b96571810e6',10.0,40.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'units','Intravenous','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288609,4454,'0c12c77c-5fd4-48dc-a318-e96892233992',NULL,NULL,NULL,NULL,NULL,'indications','DailyMed SPL Enhanced',0,NULL,NULL,NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288610,4454,'0c12c77c-5fd4-48dc-a318-e96892233992',45.0,50.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral','Solution',NULL,0,NULL,NULL,x'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',NULL,NULL,x'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',NULL,NULL,NULL,NULL,NULL,x'789cf3482d482cc94c56f0cc2d48cc2cca4dcd2b01003ff006f5',NULL,NULL),(288612,4454,'a6c24189-293f-42ca-b969-75870bb55af0',45.0,50.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral','Solution',NULL,0,NULL,NULL,x'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',NULL,NULL,x'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',NULL,NULL,NULL,NULL,NULL,x'789cf3482d482cc94c56f0cc2d48cc2cca4dcd2b01003ff006f5',NULL,NULL),(288613,4455,'0c12c77c-5fd4-48dc-a318-e96892233992',NULL,NULL,NULL,NULL,NULL,'indications','DailyMed SPL Enhanced',0,NULL,NULL,NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(288614,4455,'0c12c77c-5fd4-48dc-a318-e96892233992',45.0,50.0,NULL,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral','Solution',NULL,0,NULL,NULL,x'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',NULL,NULL,x'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',NULL,NULL,NULL,NULL,NULL,x'789cf3482d482cc94c56f0cc2d48cc2cca4dcd2b01003ff006f5',NULL,NULL);
